作者：
Marta,Rodríguez [1]
;
Ruth,Alonso-Alonso [2]
;
Laura,Tomás-Roca [1]
;
Socorro M,Rodríguez-Pinilla [2]
;
Rebeca,Manso-Alonso [1]
;
Laura,Cereceda [1]
;
Jennifer,Borregón [2]
;
Teresa,Villaescusa [1]
;
Raúl,Córdoba [1]
;
Margarita,Sánchez-Beato [2]
;
Ismael,Fernández-Miranda [1]
;
Isabel,Betancor [3]
;
Carmen,Bárcena [2]
;
Juan F,García [3]
;
Manuela,Mollejo [2]
;
Mónica,García-Cosio [4]
;
Paloma,Martin-Acosta [4]
;
Fina,Climent [1]
;
Dolores,Caballero [5]
;
Lorena,de la Fuente [2]
;
Pablo,Mínguez [6]
;
Linda,Kessler [2]
;
Catherine,Scholz [7]
;
Antonio,Gualberto [2]
;
Rufino,Mondéjar [8]
;
Miguel A,Piris [2]
作者单位：
Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.
[1]
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.
[2]
Lymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.
[3]
Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.
[4]
Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
[5]
Pathology Department, Hospital MD Anderson Cancer Center, Madrid, Spain.
[6]
Pathology Department, Hospital Virgen de la Salud, Toledo, Spain.
[7]
Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
[8]
Pathology Department, Hospital Universitario Puerta de Hierro-Segovia de Arana, Madrid, Spain.
[9]
Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
[10]
Haematology Department, Hospitalario Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain.
[11]
Bioinformatics Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
[12]
Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
[13]
Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
[14]
Kura Oncology Inc., San Diego, CA; and.
[15]
UGC Laboratorios, Hospital Universitario de Puerto Real, Cádiz, Spain.
[16]
DOI
10.1182/bloodadvances.2021005171
PMID
34592752
发布时间
2022-01-07
换一批
换一批
